Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Michael Wegmann. (2009) Th2 cells as targets for therapeutic intervention in allergic bronchial asthma. Expert Review of Molecular Diagnostics 9:1, pages 85-100.
Read now
Read now
Loren W. Hunt. (2001) How to manage difficult asthma cases. Postgraduate Medicine 109:5, pages 61-68.
Read now
Read now
I. Caroline Crocker, Kirtibala Gupta, Robert G. Townley & Manzoor M. Khan. (1998) The Profile of the Cytokines Secreted During the Generation of T-Helper Cells from Atopic Asthmatic Subjects. Journal of Asthma 35:2, pages 187-201.
Read now
Read now
Articles from other publishers (20)
Madhur D. Shastri, Wai Chin Chong, Kamal Dua, Gregory M. Peterson, Rahul P. Patel, Malik Q. Mahmood, Murtaza Tambuwala, Dinesh K. Chellappan, Nicole G. Hansbro, Shakti D. Shukla & Philip M. Hansbro. (2020) Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators. Inflammopharmacology 29:1, pages 15-33.
Crossref
Crossref
Mayumi Saeki, Tomoe Nishimura, Noriko Kitamura, Takachika Hiroi, Akio Mori & Osamu Kaminuma. (2019) Potential Mechanisms of T Cell-Mediated and Eosinophil-Independent Bronchial Hyperresponsiveness. International Journal of Molecular Sciences 20:12, pages 2980.
Crossref
Crossref
I. P. Shilovskiy, D. V. Eroshkina, A. A. Babakhin & M. R. Khaitov. (2017) Anticytokine therapy of allergic asthma. Molecular Biology 51:1, pages 1-13.
Crossref
Crossref
Suqin Zhang, Yuqin Li & Yufeng Liu. (2014) Interleukin-4 -589C/T Polymorphism is Associated with Increased Pediatric Asthma Risk: A Meta-Analysis. Inflammation 38:3, pages 1207-1212.
Crossref
Crossref
Noriko Shimura & Shuji Kojima. (2014) Effects of Low-Dose-Gamma Rays on the Immune System of Different Animal Models of Disease. Dose-Response 12:3, pages dose-response.1.
Crossref
Crossref
Girolamo Pelaia, Alessandro Vatrella & Rosario Maselli. (2012) The potential of biologics for the treatment of asthma. Nature Reviews Drug Discovery 11:12, pages 958-972.
Crossref
Crossref
Tania Maes, Guy F. Joos & Guy G. Brusselle. (2012) Targeting Interleukin-4 in Asthma: Lost in Translation?. American Journal of Respiratory Cell and Molecular Biology 47:3, pages 261-270.
Crossref
Crossref
T. Morioka, K. Yamanaka, H. Mori, Y. Omoto, K. Tokime, M. Kakeda, I. Kurokawa, E.C. Gabazza, A. Tsubura, Y. Yasutomi & H. Mizutani. (2009) IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis. British Journal of Dermatology 160:6, pages 1172-1179.
Crossref
Crossref
Markus Koch, Martin Witzenrath, Christine Reuter, Marion Herma, Hartwig Schütte, Norbert Suttorp, Helen Collins & Stefan H. E. Kaufmann. (2006) Role of Local Pulmonary IFN-γ Expression in Murine Allergic Airway Inflammation. American Journal of Respiratory Cell and Molecular Biology 35:2, pages 211-219.
Crossref
Crossref
K Nishikubo, Y Murata, S Tamaki, K Sugama, K Imanaka-Yoshida, N Yuda, M Kai, S Takamura, W Sebald, Y Adachi & Y Yasutomi. (2003) A single administration of interleukin-4 antagonistic mutant DNA inhibits allergic airway inflammation in a mouse model of asthma. Gene Therapy 10:26, pages 2119-2125.
Crossref
Crossref
Stephen T. Holgate & David Broide. (2003) New targets for allergic rhinitis — a disease of civilization. Nature Reviews Drug Discovery 2:11, pages 903-915.
Crossref
Crossref
T K HART, M N BLACKBURN, M BRIGHAM-BURKE, K DEDE, N AL-MAHDI, P ZIA-AMIRHOSSEINI & R M COOK. (2002) Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Clinical and Experimental Immunology 130:1, pages 93-100.
Crossref
Crossref
Azzeddine Dakhama & Erwin Gelfand. 2002. Biotherapeutic Approaches to Asthma. Biotherapeutic Approaches to Asthma
247
291
.
R. E. BEADLE, D. W. HOROHOV & S. D. GAUNT. (2010) Interleukin-4 and interferon-gamma gene expression in summer pasture-associated obstructive pulmonary disease affected horses. Equine Veterinary Journal 34:4, pages 389-394.
Crossref
Crossref
Kian Fan Chung. (2002) Current and potential improvements in the treatment of asthma from increased understanding of airway pathophysiology. Allergology International 51:3, pages 153-166.
Crossref
Crossref
Shelby P. Umland, Robert P. Schleimer & Sebastian L. Johnston. (2002) Review of the Molecular and Cellular Mechanisms of Action of Glucocorticoids for Use in Asthma. Pulmonary Pharmacology & Therapeutics 15:1, pages 35-50.
Crossref
Crossref
Annette M. Colavita, Alan J. Reinach & Stephen P. Peters. (2000) CONTRIBUTING FACTORS TO THE PATHOBIOLOGY OF ASTHMA. Clinics in Chest Medicine 21:2, pages 263-277.
Crossref
Crossref
Shau-Ku Huang. (1998) Molecular modulation of allergic responses. Journal of Allergy and Clinical Immunology 102:6, pages 887-892.
Crossref
Crossref
Wang & Forsyth. (1998) Asthma and respiratory syncytial virus infection in infancy: is there a link?. Clinical & Experimental Allergy 28:8, pages 927-935.
Crossref
Crossref
I Caroline Crocker, Martin K Church, Sean Newton & Robert G Townley. (1998) Glucocorticoids Inhibit Proliferation and Interleukin-4 and Interleukin-5 Secretion by Aeroallergen-Specific T-Helper Type 2 Cell Lines. Annals of Allergy, Asthma & Immunology 80:6, pages 509-516.
Crossref
Crossref